Zobrazeno 1 - 10
of 10
pro vyhledávání: '"J. B. Breitmeyer"'
Autor:
S. Yazji, S. Hamburger, Y. Wang, S. Yavrom, A. Pietrofeso, R. Bliss, J. B. Breitmeyer, M. Dreyling, M. Wang
Publikováno v:
HemaSphere, Vol 6, Pp 1041-1042 (2022)
Externí odkaz:
https://doaj.org/article/835c255917104b7d8c508be63b464804
Autor:
S. Meinke, N. Kadri, S. Bi, B. Bostancioglu, C. Markey, J. B. Breitmeyer, A. Hussain, R. Krishnan, G. F. Kaufmann, E. Alici
Publikováno v:
HemaSphere, Vol 6, Pp 1318-1319 (2022)
Externí odkaz:
https://doaj.org/article/cbd4cb4034d64a34a7b3c71f99b97933
Publikováno v:
Cancer. 66:1439-1448
The management of patients with metastatic breast cancer is best achieved by the judicious use of local and systemic measures that palliate symptoms and improve overall quality of life. When two treatment approaches are known to be equally efficaciou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71e98e0f88659fbcaa12dbb757d42d0e
https://doi.org/10.1002/1097-0142(19900915)66:14+<1439::aid-cncr2820661421>3.0.co
https://doi.org/10.1002/1097-0142(19900915)66:14+<1439::aid-cncr2820661421>3.0.co
Autor:
Susan Love, Daniel F. Hayes, I. C. Henderson, Judy Garber, Abram Recht, George P. Canellos, Leroy M. Parker, Jay R. Harris, J. B. Breitmeyer
Publikováno v:
Cancer. 65:2132-2147
Early adjuvant therapy studies, especially adjuvant chemotherapy studies, were performed almost exclusively on patients with histologically involved axillary lymph nodes ("node-positive" patients). These therapies were restricted to this group of pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36907ceec3650eee555f295470f3a939
https://doi.org/10.1002/1097-0142(19900501)65:9+<2132::aid-cncr2820651410>3.0.co
https://doi.org/10.1002/1097-0142(19900501)65:9+<2132::aid-cncr2820651410>3.0.co
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(12)
To evaluate the safety, toxicity, and maximum tolerated dose (MTD) of IFN beta-1a (Rebif, Serono Laboratories, Inc.) in patients with malignant diseases unresponsive to standard therapies and to assess the pharmacodynamics and pharmacokinetics associ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b42257845900fca228cf597b292a6424
https://pubmed.ncbi.nlm.nih.gov/10632330
https://pubmed.ncbi.nlm.nih.gov/10632330
Autor:
J B, Breitmeyer
Publikováno v:
Cancer treatment and research. 60
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::128b4a5d36a656e0ca20155d205db7d9
https://pubmed.ncbi.nlm.nih.gov/1355996
https://pubmed.ncbi.nlm.nih.gov/1355996
Autor:
I C, Henderson, D F, Hayes, L M, Parker, S, Love, J E, Garber, A, Recht, J B, Breitmeyer, J R, Harris, G P, Canellos
Publikováno v:
Cancer. 65
Early adjuvant therapy studies, especially adjuvant chemotherapy studies, were performed almost exclusively on patients with histologically involved axillary lymph nodes ("node-positive" patients). These therapies were restricted to this group of pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a912a1ce260d73a740124666538be81f
https://pubmed.ncbi.nlm.nih.gov/2183925
https://pubmed.ncbi.nlm.nih.gov/2183925
Publikováno v:
The Journal of Immunology. 140:376-383
The functional effects resulting from CD4 and CD8 perturbation were analyzed by using a CD4+CD8+ clone and anti-CD4 and anti-CD8 monoclonal antibodies. Perturbation of CD8, but not CD4, by soluble antibody resulted in the inhibition of CD3-T cell rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f6f397e30a3438ac52d1e610a63daa1
https://doi.org/10.4049/jimmunol.140.2.376
https://doi.org/10.4049/jimmunol.140.2.376
Publikováno v:
The Journal of Immunology. 139:2899-2905
Most mature human T lymphocytes express both the multichain T3 (CD3)/Ti T cell receptor for antigen (TCR), and the biochemically distinct 55-kDa T11 (CD2) glycoprotein. Stimulating the T11 molecule causes profound T cell proliferation and functional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de4e5d8e156d08ab8802a43ab3d0c08f
https://doi.org/10.4049/jimmunol.139.9.2899
https://doi.org/10.4049/jimmunol.139.9.2899
Publikováno v:
The Journal of Immunology. 138:726-731
Monoclonal antibodies that bind to the T cell MHC-antigen recognition complex (anti-T3 or anti-Ti) are known to either mimic ligand binding and activate T cells or block ligand binding, leading to an inhibition of T cell activation. In the present ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf934dcbc3e44f742bc194ca0274e5c7
https://doi.org/10.4049/jimmunol.138.3.726
https://doi.org/10.4049/jimmunol.138.3.726